Status:
NOT_YET_RECRUITING
Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
Lead Sponsor:
Armed Forces Hospital, Pakistan
Conditions:
Maternal and Neonatal Sepsis
Intrapartum Antibiotics
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother
Eligibility Criteria
Inclusion
- pregnant ladies with no risk factors for sepsis who go into spontaneous labor or induced labor
Exclusion
- pregnant with risk factors for sepsis like maternal fever , raised WBC count, chorioamnionitis, or having. history of any adverse even with macrolides
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06958146
Start Date
May 1 2025
End Date
August 31 2025
Last Update
May 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.